Javascript Disabled Detected

You currently have javascript disabled. Several functions may not work. Please re-enable javascript to access full functionality.

FDA Approves Labeling Update to Include New Sprycel Data

Started by mdszj , Aug 13 2015 04:15 PM

Please log in to reply

3 replies to this topic

#1 mdszj

Advanced Member

Members
80 posts

Posted 13 August 2015 - 04:15 PM

http://www.empr.com/...article/432507/

dx cml 7/2012; 100 mg sprycel; splenectomy 9/2012; reached prcu 10/2013; dx smoldering myeloma 1/2015; 80 mg sprycel 12/2015; 50 mg sprycel 7/13/16; discontinued sprycel 11/15/16

Back to top

#2 Trey

Advanced Member

PS Beta Group
1,705 posts

LocationSan Antonio, Texas

Posted 13 August 2015 - 08:17 PM

The summary of this is that Sprycel appears to be safe for those who have chronic kidney disease. That has not been determined for Gleevec and Tasigna.

Back to top

#3 mikefromillinois

Advanced Member

Members
93 posts

Posted 14 August 2015 - 08:26 AM

Along the same lines:

http://www.cancernet...m-cml-treatment

Back to top

#4 DebDoodah22

Advanced Member

Members
110 posts

LocationTexas

Posted 17 August 2015 - 08:33 PM

OMG...thank you Trey for the interpretation... I read the whole thing twice and although I thought I was getting it the whole read through at the end I was still wondering...what does this mean? Appreciate you!